Repeated Methylglyoxal Treatment Depletes Dopamine in the Prefrontal Cortex, and Causes Memory Impairment and Depressive-Like Behavior in Mice
Jozimar Carlos Szczepanik et al, 2020, Neurochemical Research CrossRef
Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises
Paulo Matafome et al, 2017, Medicinal Research Reviews CrossRef
Nonenzymatic Posttranslational Protein Modifications: Mechanism and Associated Disease Pathologies
Sheeza Khan et al, 2019, Protein Modificomics CrossRef
The formation of the salt and neutral molecule cocrystal from equimolar solution of heliamine and bicyclo[2.2.1]hept-5-ene-endo-2,3-dicarboxylic acid
Svitlana V. Shishkina et al, 2019, Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials CrossRef
PKM2-mediated neuronal hyperglycolysis enhances the risk of Parkinson's disease in diabetic rats
Ya Zhao et al, 2023, Journal of Pharmaceutical Analysis CrossRef
Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
Paula A. Q. Videira et al, 2018, Frontiers in Neuroscience CrossRef
Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases
C. G. Schalkwijk et al, 2020, Physiological Reviews CrossRef
Early AGEing and metabolic diseases: is perinatal exposure to glycotoxins programming for adult-life metabolic syndrome?
Flávio A Francisco et al, 2021, Nutrition Reviews CrossRef
Isolation and Sequencing of Salsolinol Synthase, an Enzyme Catalyzing Salsolinol Biosynthesis
Xuechai Chen et al, 2018, ACS Chemical Neuroscience CrossRef
Glycation in Parkinson's disease and Alzheimer's disease
Hugo Vicente Miranda et al, 2016, Movement Disorders CrossRef
Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
Sourav De et al, 2024, Journal of the Taiwan Institute of Chemical Engineers CrossRef
On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson’s Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine
Alan R. Hipkiss, 2017, Aging and disease CrossRef
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
Niklas Reich et al, 2022, Frontiers in Neuroscience CrossRef
Glycotoxins: Dietary and Metabolic Origins; Possible Amelioration of Neurotoxicity by Carnosine, with Special Reference to Parkinson’s Disease
Alan R. Hipkiss, 2018, Neurotoxicity Research CrossRef
The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality
Jyotiska Chaudhuri et al, 2018, Cell Metabolism CrossRef
Behavioral consequences of the downstream products of ethanol metabolism involved in alcohol use disorder
Otto T. Holbrook et al, 2022, Neuroscience & Biobehavioral Reviews CrossRef
Novel Synthesis of 4-Benzylidene-2-((1-phenyl-3,4-dihydroisoquinoline-2(1H)-yl)methyl) oxazol-5(4H)-one Derivatives Using 1,2,3,Tetrahydroisoquinoline and their Antimicrobial Activity
Nalla Krishna Rao et al, 2020, Current Organic Synthesis CrossRef
Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
Francesca Chiara Pignalosa et al, 2021, International Journal of Molecular Sciences CrossRef
The Adverse Influences of Sleep Disorders on Working Memory May Be Mediated by Changes in Carbohydrate Metabolism
Yu. V. Ukraintseva et al, 2023, Neuroscience and Behavioral Physiology CrossRef
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway
Justine Renaud et al, 2018, Neurobiology of Aging CrossRef
The expanding impact of methylglyoxal on behavior-related disorders
Gudrian R.L. de Almeida et al, 2023, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
Fauze Camargo Maluf et al, 2019, Parkinson's Disease CrossRef